Xyrem
NDC 68727-100, sodium oxybate, solution, from Jazz Pharmaceuticals, Inc..
- Product NDC
- 68727-100
- Status
- Listed
- Labeler
- Jazz Pharmaceuticals, Inc.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA021196
- DEA schedule
- CIII
curl https://api.healthcare.dev/v1/drugs/ndc/68727-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- SODIUM OXYBATE.5 g/mL
Pharmacologic classes
Central Nervous System Depressant [EPC]; Central Nervous System Depression [PE]; Decreased Central Nervous System Organized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68727-100-01 | 68727010001 | 180 mL in 1 BOTTLE, PLASTIC (68727-100-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/926eb076-a4a8-45e4-91ef-411f0aa4f3ca
Use it
Look up 68727-100 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68727-100 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68727-100. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.